Core Viewpoint - Rosen Law Firm is reminding purchasers of ICON plc ordinary shares about the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors without upfront costs [1][2]. Group 1: Class Action Details - The class action pertains to ICON plc ordinary shares purchased between July 27, 2023, and October 23, 2024, with a lead plaintiff deadline set for April 11, 2025 [1][2]. - Investors can join the class action by submitting a form or contacting the law firm directly for more information [2][5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success and recognition in this field [3]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Allegations Against ICON - The lawsuit alleges that ICON made false and misleading statements regarding its business performance, including a material loss of business due to customer cost reductions and funding limitations [4]. - Specific claims include that ICON's service offerings were inadequate to mitigate market downturn impacts, and that client demand was misrepresented, leading to a significant discrepancy between reported metrics and actual performance [4].

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit. https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=139916&wire=3 ICLR investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or conceale ...

SAN DIEGO, April 1, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), have until Friday, April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON as well as certain of ICON's top executive officers with violations of ...

NEW YORK, April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ICON investors who were adversely affected by alleged securities fraud between July 27, 2023 and October 23, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/icon-public-limited-compan ...

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/? id=139430&from=3 C ...

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. NEW YORK, March 31, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27 ...

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/? id=139399&from=4 CLASS ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ordinary shares of ICON plc between July 27, 2023, and October 23, 2024, about the April 11, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought ICON shares during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by April 11, 2025, to serve as lead plaintiff [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against ICON - The lawsuit alleges that ICON made false and misleading statements regarding its business performance, including suffering a material loss of business due to customer cost reductions and funding limitations [4]. - It is claimed that ICON's service offerings were insufficient to mitigate the adverse effects of a significant market downturn, and that requests for proposals were primarily used for price discovery rather than indicating actual client demand [4]. - The lawsuit also states that ICON's two largest customers were diversifying their clinical research organization providers away from ICON, leading to a misrepresentation of client demand and a failure to meet revenue and earnings per share guidance [4].

Core Viewpoint - A class action securities lawsuit has been filed against ICON Public Limited Company, alleging securities fraud that negatively impacted investors between July 27, 2023, and October 23, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's service offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools, not reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, and delayed clinical trial work, failing to enter new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their clinical research organization providers away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - The company was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until April 11, 2025, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The ICON PLC class action lawsuit alleges that the company and its executives made misleading statements regarding its business performance and failed to disclose significant operational challenges, leading to substantial financial losses for investors during the specified class period [1][2][3]. Group 1: Allegations Against ICON - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [2]. - It is alleged that ICON's Functional Service Provision (FSP) and hybrid model offerings were inadequate to mitigate the effects of a market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than indicative of actual client demand [2]. - Customers canceled contracts, limited engagements, and delayed clinical trial work, which negatively affected ICON's business [2]. - Two of ICON's largest customers were diversifying their CRO providers away from ICON, further impacting its business [2]. - As a result of these issues, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [2]. - Consequently, ICON was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Financial Performance - On October 23, 2024, ICON reported quarterly revenues of $2.03 billion, missing consensus estimates of $2.13 billion by over $100 million [3]. - The company's net new business wins declined sequentially to $2.3 billion from $2.6 billion in the prior quarter [3]. - ICON's book-to-bill ratio fell to 1.15 from 1.22 in the previous quarter, indicating a decline in business performance [3]. - Following the announcement of these results, ICON's share price dropped by more than 20% over two trading sessions [3]. Group 3: Legal Process and Representation - Investors who purchased ICON shares during the class period can seek appointment as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the plaintiffs, has a strong track record in prosecuting investor class actions and has recovered significant monetary relief for investors [6][7].